130 likes | 263 Vues
Is the cellular accumulation of antibiotics a predictive factor for intracellular efficacy ?. Sandrine Lemaire Université catholique de Louvain & Louvain Drug Research Institute Brussels, Belgium. Persistence and recurrence: the case of Staphylococcus aureus ….
E N D
Is the cellular accumulation of antibiotics a predictive factor for intracellular efficacy ? Sandrine Lemaire Université catholique de Louvain & Louvain Drug Research Institute Brussels, Belgium ISAP - 2009
Persistence and recurrence: the case of Staphylococcus aureus … Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis Ellington et al, J Bone Joint Surg (2003), 85:918-921. Intracellular persistence of Staphylococcus aureus Small Colony Variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier’s disease. von Eiff et al, Clin Infect Dis (2001), 32:1643-1647. Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the up-regulation of antiapoptotic factors. Koziel et al, PLoS One (2009), 4:e5210. Staphylococcus aureus an intracellular pathogen: the role of Small Colony Variants. Sendi and Proctor, Trends Microbiol (2009), 17:54-58 … ISAP - 2009
A simple scheme ? Phagolysosomial infection Antibacterial effect Antibiotic Cellular accumulation phagolysosomes ISAP - 2009
1st exemple: Torezolid (TR-700), a novel oxazolidinone Comparative cellular accumulation Torezolid accumulates quickly within cells, reaching an apparent cell. to extracell. concentration ratio of 12.5 – 15. ISAP - 2009
Torezolid vs. linezolid Torezolid is more active than linezolid against the intracellular forms of S. aureus (ATCC 25923) On a weight concentration basis, torezolid is 4-fold more potent than linezolid against intracellular forms of S. aureus. Lemaire et al, JAC, 2009 * Cs, Static concentration ISAP - 2009
Torezolid vs. linezolid Torezolid is more active than linezolid … Is it still true when comparing equipotent concentrations ? When data are plotted against equipotent concentration (MIC multiples), torezolid and linezolid show undistinguishable concentration-dependent activities against intracellular forms of S. aureus This indicates that the main driver of torezolid intracell. activity is not the marked cell. accum, but its higher intrinsic activity Lemaire et al, JAC, 2009 ISAP - 2009
Torezolid vs. Linezolid against others intracell. bacteria Cytosolic model Phagosomal model MICs: L.M., TR-700, 0.125 mg/L vs LZD, 1 mg/L; L.P., TR-700, 0.25 mg/L vs LZD, 8 mg/L ISAP - 2009
2nd exemple: CEM-101, a novel fluoroketolide Comparative cellular accumulation CEM-101 accumulates to a larger extent than clarithromycin (CLR) and telithromycin (TEL) ISAP - 2009
CEM-101 vs. comparators CEM-101 is more active than CLR and TEL against intracellular forms of S. aureus (strain ATCC 25923) On a weight concentration basis, CEM-101 expresses consistently greater potency (decreases values of EC50 and Cs) and slightly higher efficacy (Emax) than comparators. Lemaire et al, AAC (2009), 53:3734-3743 ISAP - 2009
CEM-101 vs. comparators If we consider equipotent concentrations of antibiotics … When data are plotted against equipotent concentration (MIC multiples), the differences in EC50 and static concentrations between drugs were minimized. This indicates that the main driver of CEM-101 intracell. activity is not the marked cell. accum, but its higher intrinsic activity * * MICs at pH 7.4: CLR, 0.5 mg/L; TEL, 0.25 mg/L; CEM-101, 0.06 mg/L Lemaire et al, AAC (2009), 53:3734-3743 ISAP - 2009
Is it still a simple scheme ??? Antibacterial effect Antibiotic Cellular accumulation These studies demonstrate the critical role of intrinsic drug activity (MIC) in eliciting the antibacterial intracellular effects of TR-700 and CEM-101 whereas their increased cellular accumulation per se play only a minimal role. ISAP - 2009
Other factors ??? Physical or biochemical Conditions prevailing in the infected site Cellular penetration Antibiotic Bacterial stress response Influx vs. efflux Metabolism Cooperation with host defences Binding ISAP - 2009
Thank you for your attention ISAP - 2009